The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

Glyphosate manufacturers reject alleged weed killer-cancer link in response to federal Roundup report

| | July 11, 2019

Glyphosate registrants defended their products as safe to use in comments submitted …. to the Department of Health and Human Service’s Agency for Toxic Substances and Disease Registry (ATSDR), which issued a report in April saying it could not “rule out” an association between exposure to glyphosate-based products and the risk of cancer.

The Joint Glyphosate Task Force, made up of 20 members with registrations for technical grade glyphosate, the active ingredient in Bayer’s Roundup, reiterated its longstanding position that the substance is safe to use, is not a reproductive toxicant or endocrine disrupter, and is unlikely to cause cancer.

[T]he JGTF also questioned the validity of studies cited by the agency that suggested glyphosate or formulations containing it may cause genetic damage. The International Agency for Research on Cancer concluded in a 2015 monograph that glyphosate is “probably” a human carcinogen ….

Related article:  Farmers need more options to conquer herbicide resistant weeds

The JGTF recommended ATSDR construct a “table of genotoxicity conclusions” from various studies so as to “highlight the very isolated, unusual and unique aspect of the IARC monograph conclusion as well as the use or non-use of a weight of evidence approach in arriving at the genotoxicity conclusions.”

Read full, original article: Glyphosate registrants defend product in comments to ATSDR

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend